Community Practice Connections™: Expert Perspectives on the Evolving Treatment Paradigm in Heart Failure Management

Release Date: December 23, 2022

Expiration Date: December 23, 2023

Activity Overview

Heart failure (HF) remains a leading cause of morbidity and mortality. Despite the fact that guideline-directed medical therapy (GDMT) has been shown to improve HF survival, GDMT optimization in clinical practice remains poor. Recent guideline updates have added an additional class of pharmacologic therapies as new tools for managing this disease. Continuing medical education is important for keeping clinicians who treat patients with HF informed of new standards of care and state-of-the-art management practices.

This Community Practice Connections™ program provides an in-depth review of some of the key highlights from a hybrid satellite symposium held adjunct to the Heart Failure Society of America Annual Scientific Meeting 2022, convened in October. This unique and engaging multimedia activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with HF, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience

This educational activity is directed toward Cardiologists, Internists, Primary Care Physicians, Endocrinologists, Nephrologists, Hospitalists, Physician Assistants, Nurse Practitioners, Pharmacists, Certified Diabetes Educators.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Identify diagnostic strategies for heart failure (HF)
• Apply evidence-based guidelines for treatment selection for HF and its comorbidities
• Outline the mechanisms of action of emerging therapies for HF
• Differentiate clinical trial evidence for emerging therapies to manage HF

Disclosures/Disclaimers

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.